Avicenna Alliance: enhanced knowledge, improved decisions, better outcomes
FULL MENU

The potential of in silico approaches to streamline drug development

The potential of in silico approaches to streamline drug development

BACK

The potential of in silico approaches to streamline drug development

This position paper highlights the potential of in silico medicine, using computational modelling and simulation to aid drug discovery, development, and delivery. It calls for adaptation of in silico technology to be a standard practice to complement in vivo and in vitro approaches in healthcare through a collaborative ecosystem of stakeholders.

The application of in silico methods before animal testing or clinical trials to obtain insights can inform decision making and thus optimise clinical trial design and patient safety. In silico methods have been suggested to complement traditional evidence with digital evidence and therefore to reduce time, cost, and environmental footprint of the regulatory approval process. However, the impact of in silico methods in regulatory decision-making and post-market surveillance remains limited. There is a strong need to develop industrial infrastructure and regulatory framework to actively incorporate CM&Sto foster medical innovation and overcome current socio-economic and technological barriers in the drug development process. We invite all the stakeholders to join arms to promote adequate use of these methods.


Download

NEWS

News Avicenna at eHealth Stakeholders group meeting

Avicenna at eHealth Stakeholders group meeting

Very interesting exchanges yesterday, during the meeting of the e-health stakeholders group organized by the European Commission.

News Avicenna Alliance at University of Toulouse

Avicenna Alliance at University of Toulouse

On February 9, Noemie Dubruel, active member of the Avicenna Alliance as a doctoral student in Droit de la santé et de la recherche médicale at the University of Toulouse 1 Capitole and Thierry Marchal spoke at the Consortium Santé in silico 6 on synthetic data and simulation in the service of clinical research, organized by Nicolas Savy.

News Abimed is a new Avicenna Partner!

Abimed is a new Avicenna Partner!

We are delighted to welcome Abimed as a new Avicenna Partner.

Sign up for our monthly newsletter!

Sign up for our monthly newsletter!

Fill in the fields you find below

Avicenna Alliance is an initiative of:

Avicenna VPH

© 2018-2024 Avicenna Alliance | powered by We Berry